Search for: "Merck & Company, Inc." Results 321 - 340 of 446
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
31 May 2009, 2:37 am
Young is the first named inventor of US 5,104,882, which ALSO arose out of Merck Frosst Canada, Inc. [read post]
19 May 2009, 2:36 am
"The lawsuit also claims that Elkin attempted to sell the software to Merck & Co., Inc. [read post]
16 Apr 2009, 7:27 am
" Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders. [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
20 Mar 2009, 1:19 am
The Securities and Exchange Commission dropped its charges against the former general counsel of McAfee Inc. in a Thursday court filing. [read post]
16 Mar 2009, 11:20 am
  The report points out that this new analysis was funded by Amylin Pharmaceuticals Inc., the drug company that makes Byetta, and Eli Lilly & Co., which is Amylin's marketing partner for Byetta sales in the U.S. [read post]
9 Mar 2009, 9:52 pm
On the heels of Pfizer's $68 billion acquisition of Wyeth (see "Pfizer Expected to Announce Wyeth Acquisition on Monday") in January, Merck & Co., Inc. and Schering-Plough Corp. announced today that their Boards of Directors had unanimously approved a definitive merger agreement under which Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough stock and each share of Merck stock will become a… [read post]
8 Mar 2009, 10:48 pm
MarketWatch reports: Pharmaceutical giant Merck & Co., Inc on March 9 said it will buy rival Schering-Plough for $41.1 billion in cash and shares to expand its presence in emerging markets and bolster its pipeline of potential new medicines.The two companies, which announced significant job cuts last fall, already are partners on the cholesterol drugs Zetia and Vytorin. [read post]
20 Feb 2009, 5:04 am
Remember, this is pediatric surgery, and very few companies sell either drugs or devices specifically intended and approved for use in children. [read post]